| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |